GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmiva AB (OSTO:PHARM) » Definitions » EPS (Basic)

Pharmiva AB (OSTO:PHARM) EPS (Basic) : kr-1.50 (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Pharmiva AB EPS (Basic)?

Pharmiva AB's basic earnings per share (Basic EPS) for the three months ended in Jun. 2023 was kr-0.35. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2023 was kr-1.50.

Pharmiva AB's EPS (Diluted) for the three months ended in Jun. 2023 was kr-0.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was kr-1.50.

Pharmiva AB's EPS without NRI for the three months ended in Jun. 2023 was kr-0.35. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was -1.50.

During the past 3 years, the average EPS without NRI Growth Rate was -25.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Pharmiva AB's highest 3-Year average EPS without NRI Growth Rate was -25.80% per year. The lowest was -25.80% per year. And the median was -25.80% per year.


Pharmiva AB EPS (Basic) Historical Data

The historical data trend for Pharmiva AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmiva AB EPS (Basic) Chart

Pharmiva AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EPS (Basic)
-1.22 -1.74 -3.15 -2.43

Pharmiva AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.90 -0.49 -0.35 -0.31 -0.35

Pharmiva AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pharmiva AB's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as

Basic EPS (A: Dec. 2022 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-23.672-0)/17.376
=-1.36

Pharmiva AB's Basic EPS for the quarter that ended in Jun. 2023 is calculated as

Basic EPS (Q: Jun. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-6.053-0)/17.376
=-0.35

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmiva AB  (OSTO:PHARM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pharmiva AB EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Pharmiva AB's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmiva AB (OSTO:PHARM) Business Description

Traded in Other Exchanges
N/A
Address
Sankt Lars Väg 45B, Lund, SWE, 222 70
Pharmiva AB is a medical technology company. It develops innovative antibiotic-free medical products in order to improve vaginal health.

Pharmiva AB (OSTO:PHARM) Headlines

No Headlines